In the anti- ulcer drug market, combination drugs of PPI+ antacids have been released. This time, it is a drug that combines Rabeprazole and sodium bicarbonate. The PPI+ antacids, which started with Chong Kun Dang's Eso Duo (Esomeprazole Magnesium Trihydrate+Sodium Bicarbonate), continues to develop new products.

The MFDS approved Youngjin Pharmaceutical's Rabenew, Ildong Pharmaceutical's Rabietduo, Dongwha's Rabeduet, Samjin's Rabeol Duo, Whanin's Rabemore, and Dong-A ST Rabiduo on the 31st.

These products are combination drugs that combine the PPI formulation Rabeprazole Sodium and the antacids Sodium Bicarbonate. Youngjin is in charge of all production.

The new combinati